참고문헌
- Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 97: 364−372, 1989
- Chang T, Wu L, Wang R. Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment. Am J Physiol Heart Circ Physiol 295: H999−H1007, 2008 https://doi.org/10.1152/ajpheart.01289.2007
- Dong Y, Chi SL, Borowsky AD, Fan Y, Weiss RH. Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells. Cell Signal 16: 263−269, 2004 https://doi.org/10.1016/S0898-6568(03)00136-0
- Duckers HJ, Boehm M, True al., Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693−698, 2001 https://doi.org/10.1038/89068
- Dulic V, Lees E, Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958−1961, 1992 https://doi.org/10.1126/science.1329201
- Englberger L, Kipfer B, Berdat PA, Nydegger UE, Carrel TP. Aprotinin in coronary operation with cardiopulmonary bypass: does 'low-dose' aprotinin inhibit the inflammatory response? Ann Thorac Surg 73: 1897−1904, 2002 https://doi.org/10.1016/S0003-4975(02)03535-X
- Hunter T. Braking the cycle. Cell 75: 839−841, 1993 https://doi.org/10.1016/0092-8674(93)90528-X
- Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38: 581−587, 2001 https://doi.org/10.1161/hy09t1.096249
- Jeon EM, Choi HC, Lee KY, Chang KC, Kang YJ. Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21. Arch Pharm Res 32: 375−382, 2009 https://doi.org/10.1007/s12272-009-1310-2
- Lee DH, Choi HC, Lee KY, Kang YJ. Aprotinin inhibits vascular smooth muscle cell inflammation and proliferation via induction of HO-1. Korean J Physiol Pharmacol 13: 123−130, 2009 https://doi.org/10.4196/kjpp.2009.13.2.123
- Levy JH. Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 72: S1814−1820, 2001 https://doi.org/10.1016/S0003-4975(01)03218-0
- Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354: 353−365, 2006 https://doi.org/10.1056/NEJMoa051379
- McEvoy MD, Taylor AG, Zavadzkas JA, Mains IM, Ford RL, Stroud RE, Jeffords LB, Beck CU, Reeves ST, Spinale FG. Aprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion. Ann Thorac Surg 86: 568−575, 2008 https://doi.org/10.1016/j.athoracsur.2008.04.025
- Ndisang JF, Wu L, Zhao W, Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101: 3893−3900, 2003 https://doi.org/10.1182/blood-2002-08-2608
- Ndisang JF, Zhao W, Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 40: 315−321, 2002 https://doi.org/10.1161/01.HYP.0000028488.71068.16
- Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ann Thorac Surg 86: 1195−1202, 2008 https://doi.org/10.1016/j.athoracsur.2008.06.048
- Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, Wang H, Schafer AI, Durante W. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99: 4443−4448, 2002 https://doi.org/10.1182/blood.V99.12.4443
- Resink TJ, Scott-Burden T, Baur U, Buhler FR. Increased proliferation fate and phosphoinositide turnover in cultured smooth muscle cells from spontaneously hypertensive rats. J Hypertens Suppl 5: S145−148, 1987 https://doi.org/10.1097/00004872-198712004-00025
- Sherr CJ. Cancer cell cycles. Science 274: 1672−1677, 1996 https://doi.org/10.1126/science.274.5293.1672
- Sherr CJ. Mammalian G1 cyclins. Cell 73: 1059−1065, 1993 https://doi.org/10.1016/0092-8674(93)90636-5
- Taille C, Almolki A, Benhamed M, Zedda C, Megret J, Berger P, Leseche G, Fadel E, Yamaguchi T, Marthan R, Aubier M, Boczkowski J. Heme oxygenase inhibits human airway smooth muscle proliferation via a bilirubin-dependent modulation of ERK1/2 phosphorylation. J Biol Chem 278: 27160−27168, 2003 https://doi.org/10.1074/jbc.M300364200
- Tanner FC, Greutert H, Barandier C, Frischknecht K, Luscher TF. Different cell cycle regulation of vascular smooth muscle in genetic hypertension. Hypertension 42: 184−188, 2003 https://doi.org/10.1161/01.HYP.0000082360.65547.7C
- Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48: 685−692, 2006 https://doi.org/10.1161/01.HYP.0000239673.80332.2f
- Westaby S. Aprotinin in perspective. Ann Thorac Surg 55: 1033−1041, 1993 https://doi.org/10.1016/0003-4975(93)90149-C